Position in NVS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$200,288
New position
Shares Held
1,278
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,320
of 1,603 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atwater Malick LLC holds $12,919,723 across 8 Drug Manufacturers - General names. NVS ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
27,778 | $7,054,778 | |
| 2 | NVO |
Novo Nordisk A S
|
57,670 | $2,764,699 | |
| 3 | LLY |
ELI LILLY & Co
|
1,015 | $1,217,421 | |
| 4 | ABBV |
AbbVie Inc.
|
3,342 | $840,980 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,527 | $324,719 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,245 | $283,633 | |
| 7 | AMGN |
Amgen Inc
|
644 | $233,205 | |
| 8 | NVS |
Novartis AG
This page
|
1,278 | $200,288 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $200,288 | 1,278 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||